DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
ADL5859 is an investigational drug.
There have been 4 clinical trials for ADL5859. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2007.
The most common disease conditions in clinical trials are Arthritis, Peripheral Nervous System Diseases, and Neuralgia. The leading clinical trial sponsors are Cubist Pharmaceuticals LLC, Pfizer, and [disabled in preview].
Recent Clinical Trials for ADL5859
|Efficacy and Safety Study Evaluating ADL5859 and ADL5747 in Participants With Pain Due to Osteoarthritis of the Knee||Pfizer||Phase 2|
|Efficacy and Safety Study Evaluating ADL5859 and ADL5747 in Participants With Pain Due to Osteoarthritis of the Knee||Cubist Pharmaceuticals LLC||Phase 2|
|Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy||Cubist Pharmaceuticals LLC||Phase 2|